Christopher J Petit, Andrew C Glatz, Andrew B Goldstone, Mark A Law, Jennifer C Romano, Shiraz A Maskatia, Paul J Chai, Jeffrey D Zampi, Jeffery J Meadows, George T Nicholson, Shabana Shahanavaz, Athar M Qureshi, Courtney E McCracken, Christopher E Mascio, Sarosh P Batlivala, Ivor B Asztalos, Steven J Healan, Justin D Smith, Joelle A Pettus, Asaad Beshish, James E B Raulston, Krissie M Hock, Amy L Pajk, Bryan H Goldstein
BACKGROUND: Neonates with symptomatic tetralogy of Fallot (sTOF) with hypoplastic pulmonary arteries (hPA) are considered high risk. Data are needed to inform the impact of hPA on outcomes, and the ideal management strategy. OBJECTIVES: The objectives of this study were to quantify the impact of hPA on outcomes in neonates with sTOF and measure the impact of strategy on pulmonary artery (PA) growth in this population. METHODS: Neonates with sTOF from 2005 to 2017 were reviewed from the Congenital Cardiac Research Collaborative...
August 15, 2023: Journal of the American College of Cardiology